Association of Plasma Leptin, Homocysteine and Nitric Oxide Levels With the Presence and Unstability of Coronary Artery Disease

References

• Lau DC , DhillonB, YanH, SzmitkoPE, VermaS. Adipokines: molecular links between obesity and atheroslcerosis. Am. J. Physiol. Heart Circ. Physiol.288(5), H2031–H2041 (2005).
   PubMed Web of Science ®Google Scholar
• Jéquier E. Leptin signaling, adiposity, and energy balance. Ann. NY Acad. Sci.967, 379–388 (2002 .
   PubMed Web of Science ®Google Scholar
• Martin SS , QasimA, ReillyMP. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J. Am. Coll. Cardiol.52(15), 1201–1210 (2008).
   PubMed Web of Science ®Google Scholar
• Bouloumié A , MarumoT, LafontanM, BusseR. Leptin induces oxidative stress in human endothelial cells. FASEB J.13(10), 1231–1238 (1999).
   PubMed Web of Science ®Google Scholar
• Bodary PF , WestrickRJ, WickenheiserKJ, ShenY, EitzmanDT. Effect of leptin on arterial thrombosis following vascular injury in mice. JAMA287(13), 1706–1709 (2002).
   PubMed Web of Science ®Google Scholar
• Wolk R , SomersVK. Leptin and vascular function: friend or foe? Eur. Heart J. 27(19), 2263–2265 (2006).
   PubMed Web of Science ®Google Scholar
• Gherman CD , MironiucAI. Evaluation of serum adipokines in peripheral arterial occlusive disease. Mediators Inflamm.2012, 257808 (2012).
   PubMed Web of Science ®Google Scholar
• Smith C , MocanuM, DavidsonS, WynneA, SimpkinJ, YellonD. Leptin, the obesity‐associated hormone, exhibits direct cardioprotective effects. Br. J. Pharmacol.149(1), 5–13 (2006).
   PubMed Web of Science ®Google Scholar
• Brennan A , LiT, KelesidisI, GavrilaA, HuF, MantzorosC. Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: a prospective cohort study. Diabetologia50(6), 1178–1185 (2007).
   PubMed Web of Science ®Google Scholar
• Couillard C , LamarcheB, MauriègePet al. Leptinemia is not a risk factor for ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study. Diabetes Care21(5), 782–786 (1998).
   PubMed Web of Science ®Google Scholar
• Karakas M , ZiererA, HerderCet al. Leptin, adiponectin, their ratio and risk of coronary heart disease: results from the MONICA/KORA Augsburg Study 1984–2002. Atherosclerosis209(1), 220–225 (2010).
   PubMed Web of Science ®Google Scholar
• Lawlor DA , SmithGD, KellyA, SattarN, EbrahimS. Leptin and coronary heart disease risk: prospective case control study of British women. Obesity15(7), 1694–1701 (2007).
   PubMed Web of Science ®Google Scholar
• Ku IA , Farzaneh-FarR, VittinghoffE, ZhangMH, NaB, WhooleyMA. Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: The Heart and Soul Study. Atherosclerosis217(2), 503–508 (2011).
   PubMed Web of Science ®Google Scholar
• Tayama J , MunakataM, YoshinagaK, ToyotaT. Higher plasma homocysteine concentration is associated with more advanced systemic arterial stiffness and greater blood pressure response to stress in hypertensive patients. Hypertens. Res.29(6), 403 (2006). •
   PubMed Web of Science ®Google Scholar
• Becker JS , AdlerA, SchneebergerAet al. Hyperhomocysteinemia, a cardiac metabolic disease role of nitric oxide and the p22phox subunit of NADPH oxidase. Circulation111(16), 2112–2118 (2005). ••
   PubMed Web of Science ®Google Scholar
• Chan N , VallanceP, ColhounH. Nitric oxide and vascular responses in Type I diabetes. Diabetologia43(2), 137–147 (2000).
   PubMed Web of Science ®Google Scholar
• Basati G , PourfarzamM, MovahedianA, SamsamshariatSZ, SarrafzadeganN. Reduced plasma adiponectin levels relative to oxidized low density lipoprotein and nitric oxide in coronary artery disease patients. Clinics (Sao Paulo)66(7), 1129–1135 (2011).
   PubMed Web of Science ®Google Scholar
• Samsamshariat SZ , BasatiG, MovahedianA, PourfarzamM, SarrafzadeganN. Elevated plasma myeloperoxidase levels in relation to circulating inflammatory markers in coronary artery disease. Biomarkers5(3), 377–385 (2011).
   Web of Science ®Google Scholar
• Beltowski J , WójcickaG, MarciniakA, JamrozA. Oxidative stress, nitric oxide production, and renal sodium handling in leptin-induced hypertension. Life Sci.74(24), 2987 (2004).
   PubMed Web of Science ®Google Scholar
• Lembo G , VecchioneC, FrattaLet al. Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes49(2), 293–297 (2000).
   PubMed Web of Science ®Google Scholar
• Cassar A , HolmesDRJr, RihalCS, GershBJ. Chronic coronary artery disease: diagnosis and management. Mayo Clin. Proc.84(12), 1130–1146 (2009).
   PubMed Web of Science ®Google Scholar
• Braunwald E , JonesRH, MarkDBet al. Diagnosing and managing unstable angina. Agency for Health Care Policy and Research. Circulation90(1), 613–622 (1994).
   PubMed Web of Science ®Google Scholar
• Tsikas D. Analysis of nitrite and nitrate in biological fluids by assays based on the Griess reaction: appraisal of the Griess reaction in the L-arginine/nitric oxide area of research. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.851 (1–2), 51 (2007).
   PubMed Web of Science ®Google Scholar
• Dubey L , ZengH-S, WangH-J, LiuR-Y. Potential role of adipocytokine leptin in acute coronary syndrome. Asian Cardiovasc. Thorac. Ann.16(2), 124 (2008).
   PubMedGoogle Scholar
• Momin AU , MelikianN, ShahAMet al. Leptin is an endothelial-independent vasodilator in humans with coronary artery disease: evidence for tissue specificity of leptin resistance. Eur. Heart J.27(19), 2294–2299 (2006).
   PubMed Web of Science ®Google Scholar
• Vecchione C , MaffeiA, ColellaSet al. Leptin effect on endothelial nitric oxide is mediated through Akt–endothelial nitric oxide synthase phosphorylation pathway. Diabetes51(1), 168–173 (2002).
   PubMed Web of Science ®Google Scholar
• Wolk R , DebA, CapliceNM, SomersVK. Leptin receptor and functional effects of leptin in human endothelial progenitor cells. Atherosclerosis183(1), 131–139 (2005).
   PubMed Web of Science ®Google Scholar
• Knudson JD , DincerÜD, ZhangCet al. Leptin receptors are expressed in coronary arteries, and hyperleptinemia causes significant coronary endothelial dysfunction. Am. J. Physiol. Heart Circ. Physiol.289(1), H48–H56 (2005).
   PubMed Web of Science ®Google Scholar
• Nakata M , YadaT, SoejimaN, MaruyamaI. Leptin promotes aggregation of human platelets via the long form of its receptor. Diabetes48(2), 426–429 (1999).
   PubMed Web of Science ®Google Scholar
• Loffreda S , YangS, LinHet al. Leptin regulates proinflammatory immune responses. FASEB J.12(1), 57–65 (1998).
   PubMed Web of Science ®Google Scholar
• Mark AL , CorreiaML, RahmouniK, HaynesWG. Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J. Hypertens.20(7), 1245–1250 (2002).
   PubMed Web of Science ®Google Scholar
• Stangl K , CascorbiI, LauleMet al. Elevated serum leptin in patients with coronary artery disease: no association with the Trp64Arg polymorphism of the b3-adrenergic receptor. Int. J. Obes. Relat. Metab. Disord.24(3), 369–375 (2000).
   PubMed Web of Science ®Google Scholar
• Meisel SR , EllisM, ParienteCet al. Serum leptin levels increase following acute myocardial infarction. Cardiology95(4), 206–211 (2001).
   PubMed Web of Science ®Google Scholar
• Stejskal D , RůzickaV, BartekJ, HoralíkD. Leptinemia in persons with acute myocardial infarct]. Vnitřní Lékařství44(10), 588–592 (1998).
   PubMedGoogle Scholar
• Maingrette F , RenierG. Leptin increases lipoprotein lipase secretion by macrophages: involvement of oxidative stress and protein kinase C. Diabetes52(8), 2121–2128 (2003).
   PubMed Web of Science ®Google Scholar
• Malinow M. Homocyst(e)ine and arterial occlusive diseases. J. Intern. Med.236(6), 603–617 (1994).
   PubMed Web of Science ®Google Scholar
• Malinow MR , DuellPB, HessDLet al. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N. Engl. J. Med.338(15), 1009–1015 (1998).
   PubMed Web of Science ®Google Scholar
• Mayer EL , JacobsenDW, RobinsonK. Homocysteine and coronary atherosclerosis. J. Am. Coll. Cardiol.27(3), 517–527 (1996).
   PubMed Web of Science ®Google Scholar
• Nygård O , NordrehaugJE, RefsumH, UelandPM, FarstadM, VollsetSE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N. Engl. J. Med.337(4), 230–237 (1997).
   PubMed Web of Science ®Google Scholar
• Lentz SR. Does homocysteine promote atherosclerosis? Arterioscler. Thromb. Vasc. Biol. 21(9), 1385–1386 (2001).
   PubMed Web of Science ®Google Scholar
• Vita JA , BrennanM-L, GokceNet al. Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation110(9), 1134–1139 (2004).
   PubMed Web of Science ®Google Scholar
• Widlansky ME , GokceN, KeaneyJF, VitaJA. The clinical implications of endothelial dysfunction. J. Am. Coll. Cardiol.42(7), 1149–1160 (2003).
   PubMed Web of Science ®Google Scholar
• Lyon CJ , LawRE, HsuehWA. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology144(6), 2195–2200 (2003).
   PubMed Web of Science ®Google Scholar
• Vita JA , KeaneyJFJr. Endothelial function a barometer for cardiovascular risk?Circulation106(6), 640–642 (2002).
   PubMed Web of Science ®Google Scholar
• Coffey M , CrowderGK, CheekDJ. Reducing coronary artery disease by decreasing homocysteine levels. Crit. Care Nurse23(1), 25–30 (2003).
   PubMedGoogle Scholar